Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 31, 2025
Traws Pharma Reports Full Year 2024 Results and Business Highlights
GlobeNewswire
·
March 31, 2025
Tivoxavir marboxil’s potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted animal models and positive Phase 1 data Ongoing FDA interaction to align on path forward for tivoxavir …
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial
GlobeNewswire
·
March 31, 2025
IRVINE, Calif. and CHICAGO, March 31, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, presented results from an expanded cohort of 500 patients in the ALIGN-AR Pivotal …
Prime Biome Reviews [DOCTOR INVESTIGATION TRUTH]: The Revolutionary Supplement Transforming Gut Health & Wellness
GlobeNewswire
·
March 31, 2025
ORLANDO, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- The pioneering solution Prime Biome provides USA residents with a way to recover their microbiome equilibrium and boost their digestive abilities and help their immune systems work more effectively. Prime …
Mitolyn Reviews (2025 WARNING): Is This Popular Metabolic Supplement Safe, or a Biohacking Hoax?
GlobeNewswire
·
March 31, 2025
Bellingham, WASHINGTON, March 31, 2025 (GLOBE NEWSWIRE) -- Mitolyn When it comes to weight loss supplements, consumer experiences and real-world results matter more than marketing hype. With Mitolyn gaining rapid attention, people are asking the same …
Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results
GlobeNewswire
·
March 31, 2025
Lead program investigating MT-601 in patients with refractory lymphomas, including anti-CD19 CAR-T cell therapy, demonstrated safety and efficacy in 9 patients with 78% having objective responses, including durable complete responses Secured over $13 …
WittKieffer Publishes Groundbreaking Report on the Healthcare CEO Role
GlobeNewswire
·
March 31, 2025
Oak Brook, Illinois, March 31, 2025 (GLOBE NEWSWIRE) -- WittKieffer, the premier executive search and leadership advisory firm improving quality of life through impactful leadership, today announced the release of a new, comprehensive report on the …
Noom To Streamline Access to Zepbound® Vials with Noom GLP-1 Companion Through Integration with LillyDirect® Pharmacy Provider
GlobeNewswire
·
March 31, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced an agreement with Eli Lilly and Company’s LillyDirect® pharmacy …
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
GlobeNewswire
·
March 31, 2025
MALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025
GlobeNewswire
·
March 31, 2025
SOLANA BEACH, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and …
LB Pharmaceuticals Presents New Data from Phase 2 Clinical Trial of LB-102 at the 2025 Annual Congress of the Schizophrenia International Research Society
GlobeNewswire
·
March 31, 2025
Treatment with LB-102 resulted in a positive shift in disease severity as measured by mean change from baseline in Clinical Global Impression of Severity (CGI-S) scores Phase 3 clinical trial of LB-102 in acute schizophrenia expected to initiate in Q4 2025 …
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
GlobeNewswire
·
March 31, 2025
Pre-Clinical Study in Collaboration with Netherlands Cancer Institute is in addition to LIXTE’s Ongoing Clinical Trials for Ovarian and Colorectal Cancers PASADENA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or …
Aprea Therapeutics Announces Dosing of Patient with HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Ongoing ACESOT-1051 Trial
GlobeNewswire
·
March 31, 2025
DOYLESTOWN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while …
Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 31, 2025
BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood vessel function, …
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
GlobeNewswire
·
March 31, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has integrated Arabic as …
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
March 31, 2025
MIAMI, FL, March 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that Mitchell …
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
GlobeNewswire
·
March 31, 2025
Conduit secures a composition of matter patent from the USPTO for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and strategic partnerships. NAPLES, Fla. and CAMBRIDGE, …
SS Innovations Achieves Significant Milestones in 2024
GlobeNewswire
·
March 31, 2025
The Company’s award winning SSi Mantra surgical robotic system has completed over 3,500 surgeries and is clinically validated to perform more than 100 different types of surgical procedures The Company Continues to Build a Strong Foundation for Future …
Safety Shot Provides Business Update from CEO Jarrett Boon
GlobeNewswire
·
March 31, 2025
SCOTTSDALE, Ariz., March 31, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company, today provides a business update from CEO Jarrett Boon. To our valued stakeholders, As we …
Opus Genetics Announces Financial Results for Full Year 2024
GlobeNewswire
·
March 31, 2025
Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited retinal diseases Strong cash position with $21.5 million financing to supplement $30.3 million year-end balance New capital supports …
Oncotelic Therapeutics Publishes New Research Demonstrating Positive Prognostic Impact of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients, Introduces Interactive PDAOAI
GlobeNewswire
·
March 31, 2025
AGOURA HILLS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic,” the “Company,” or “We”), a leader in RNA-based therapeutics, today announced the publication of its latest research paper, titled, “Positive …